In its core markets, Possis' current total realizable U.S. AngioJet opportunity is $440 million. By 2010, accross the board increases in the sizes of the coronary, peripheral and AV-Access markets, combined with the new markets of PE and DVT, will lift our total realizable AngioJet opportunity to $675 million.